Evidence map›Paper›PMID 35041567›Full record

ArticleHuman vaccines & immunotherapeutics2021

Adaptation and validation of the Turkish version of the vaccine hesitancy 5 point Likert Scale.

Kübra Temel Aslan, Pınar Ay, Dilara Kaş, Furkan Tosun, İrem Yürükcü, Emre Kekeç, Muhammet Furkan Şahin, Çiğdem Apaydın Kaya

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Optimizing acquisition time and injected dose inBMC medical informatics and decision making · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kübra Temel AslanDepartment of Family Medicine, Marmara University School of Medicine, Istanbul, Turkey.
Pınar AyDepartment of Public Health, Marmara University School of Medicine, Istanbul, Turkey.
Dilara KaşMarmara University School of Medicine, Istanbul, Turkey.
Furkan TosunMarmara University School of Medicine, Istanbul, Turkey.
İrem YürükcüMarmara University School of Medicine, Istanbul, Turkey.
Emre KekeçMarmara University School of Medicine, Istanbul, Turkey.
Muhammet Furkan ŞahinMarmara University School of Medicine, Istanbul, Turkey.
Çiğdem Apaydın KayaDepartment of Family Medicine, Marmara University School of Medicine, Istanbul, Turkey.ORCID 0000-0003-4786-6760

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The decrease in vaccine acceptance has been recognized as an emerging public health problem and there is therefore a need for reliable and validated tools that identify vaccine hesitancy. The objective of this study was to adapt and validate the Turkish version of the Vaccine Hesitancy 5-point Likert Scale which was originally developed by the WHO Strategic Advisory Group of Experts on Immunization. The study was carried out in a Family Health Center (FHC) in Istanbul over the period June 1-November 30, 2020. The participants were parents who had applied to the FHC for well-child visits and had a child ≤18 months of age. After the process of translation and back-translation, the Turkish version was pilot-tested, and its test-retest reliability was evaluated among 40 parents at a two-week interval. The validation was carried out with 306 parents through exploratory factor analysis. There was no statistical difference between the test-retest scores (

Indexed as

TranslationsVaccination HesitancyHumansParentsReproducibility of ResultsSurveys and QuestionnairesimmunizationreliabilityscalevaccineVaccine hesitancyvalidity

Identifiers

PMID35041567
PMCPMC8903923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.